CTAD 2025

Neurodegenerative
-
San Diego
,
United States of America
Conference Website

We will be present at this event with meeting spaces available. 

Poster Sessions:

Wednesday, December 3, 7:15am - 5:30pm: Group 7: "CLINICAL TRIALS: BIOMARKERS INCLUDING PLASMA"

  • P236 ADxPLORER: filling the gap for early-stage fluid biomarker research on the fully automated LUMIPULSE® G1200 Platform 
    • Presenter: Nathan Blancke, ADx NeuroSciences
  • P234 Performance testing of the novel DDC Xplorer Lumipulse G1200 immunoassay for measuring DOPA Decarboxylase in Cerebrospinal Fluid (CSF) 
    • Presenter: Erik Stoops, ADx NeuroSciences

 

Flash Presentation:

Wednesday, December 3, 3:50pm - 4:20pm: Session 4 - Multiomics and Precision Diagnostics

  • Fujirebio/ADx NeuroSciences — ADxPLORER qualified assays for early biomarker access "The chicken or the egg - why is ADxPLORER filling a crucial gap?"

 

Late Breaking Communications (LUMIPULSE):

Thursday, December 4, 8:45am

  • LB24 pTau 217 performance to separate Alzheimer's disease biological stage is not increased by adding demographic or clinical information
    • Contributor Mention: Manu Vandijck, Fujirebio Europe N.V. - Gent (Belgium)

Please contact us to schedule a meeting or for additional information.

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.